1.Date the fine was imposed: May 1, 2020

2.Recipient of the fine: Vetco Pharmaceuticals Inc.

3.Legal basis of the fine:  Paragraph 1(1) of Article 36 , Paragraph 1(4) of Article 178 and Article 179 of the Securities and Exchange Act. and Paragraph 1(1) of Article 3 of the Regulations Governing the Applicable Scope of Special Circumstances for the Public Announcement and Filing of Financial Reports and Operational Status Reports by Public Companies

4.Facts of the violation and reasons:It was found that Vetco Pharmaceuticals Inc. failed to complete the regulatory filing of the financial statement for 2019.

5.Resulting fine:Sentenced to the fine for the responsible person of the company, NT$240,000, in accordance with Paragraphs 1(1) of Article 36, Paragraph 1(4) of Article 178 and Article 179 of the Securities and Exchange Act and Paragraph 1(1) of Article 3 of the Regulations Governing the Applicable Scope of Special Circumstances for the Public Announcement and Filing of Financial Reports and Operational Status Reports by Public Companies.